Drug Type Mesenchymal stem cell therapy |
Synonyms gMSC1 |
Target- |
Action- |
Mechanism Cartilage replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cartilage Injury | Phase 3 | Japan | 31 Oct 2017 | |
Osteochondritis Dissecans | Phase 3 | Japan | 31 Oct 2017 | |
Intervertebral Disc Disease | Preclinical | Japan | 01 Feb 2025 | |
Ligament injury | Preclinical | Japan | 01 Feb 2025 | |
Meniscus disorder | Preclinical | Japan | 01 Feb 2025 | |
Osteoarthritis, Knee | Preclinical | Japan | 01 Feb 2025 |